Bicarbonate

Bicarbonate

SCHEMBL31055609

O=C(O)O.O=C(O)O.O=C(O)O.Oc1c(O)c(O)c(O)c(O)c1O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.56
CA2 P00918 5/20 0.56
CA9 Q16790 5/20 0.56
CA12 O43570 4/20 0.37
CA7 P43166 4/20 0.37
CA14 Q9ULX7 4/20 0.37
SELL P14151 2/20 0.37
SELP P16109 2/20 0.37
DPP4 P27487 2/20 0.37
CA3 P07451 2/20 0.37
CA4 P22748 2/20 0.37
CA6 P23280 2/20 0.37
CA5A P35218 2/20 0.37
CA5B Q9Y2D0 2/20 0.37
TP53 P04637 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL28095841 0.76
Bicarbonate SCHEMBL1250901 0.74 CA1 (1.00) CA1CA2CA9TP53ALDH1A1
Bicarbonate SCHEMBL6478072 0.74 CA1 (1.00) CA1CA2CA9TP53ALDH1A1
Bicarbonate SCHEMBL570968 0.74 CA1 (1.00) CA1CA2CA9TP53ALDH1A1
Bicarbonate SCHEMBL7794 0.74
Bicarbonate SCHEMBL8322803 0.74 CA1 (1.00) CA1CA2CA9TP53ALDH1A1
Bicarbonate SCHEMBL570721 0.74 CA1 (1.00) CA1CA2CA9TP53ALDH1A1
Bicarbonate SCHEMBL15271537 0.74
Bicarbonate SCHEMBL1179 0.74
Bicarbonate SCHEMBL11066368 0.74 CA1 (1.00) CA1CA2CA9TP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260112694-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2026-04-23 US claimed
US-20260088310-A1 SHAPED BATTERY CELL AND METHOD OF MANUFACTURE Anthro Energy, Inc. (US) 2026-03-26 US claimed
EP-4666334-A2 GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION Anthro Energy, Inc. (US) 2025-12-24 EP claimed
US-20250372706-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2025-12-04 US claimed
US-12482860-B2 System and method for improved battery structural properties Anthro Energy, Inc. (US) 2025-11-25 US claimed
US-20250273736-A1 FLEXIBLE BATTERY Anthro Energy, Inc. (US) 2025-08-28 US claimed
US-20250149631-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2025-05-08 US claimed
WO-2025091014-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2025-05-01 WO claimed
US-20250087748-A1 GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION Anthro Energy, Inc. (US) 2025-03-13 US claimed
US-12191447-B2 Gel electrolyte composition for a battery and a method of implementation Anthro Energy, Inc. (US) 2025-01-07 US claimed
WO-2024173770-A2 GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION Anthro Energy, Inc. (US) 2024-08-22 WO claimed
US-20240283017-A1 GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION Anthro Energy, Inc. (US) 2024-08-22 US claimed
US-20260112694-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2026-04-23 US disclosed
US-20260088310-A1 SHAPED BATTERY CELL AND METHOD OF MANUFACTURE Anthro Energy, Inc. (US) 2026-03-26 US disclosed
EP-4666334-A2 GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION Anthro Energy, Inc. (US) 2025-12-24 EP disclosed
US-20250372706-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES Anthro Energy, Inc. (US) 2025-12-04 US disclosed
US-12191447-B2 Gel electrolyte composition for a battery and a method of implementation Anthro Energy, Inc. (US) 2025-01-07 US disclosed
US-20240283016-A1 GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION Anthro Energy, Inc. (US) 2024-08-22 US disclosed
WO-2024173770-A2 GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION Anthro Energy, Inc. (US) 2024-08-22 WO disclosed
US-20240283017-A1 GEL ELECTROLYTE COMPOSITION FOR A BATTERY AND A METHOD OF IMPLEMENTATION Anthro Energy, Inc. (US) 2024-08-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260088310-A1 SHAPED BATTERY CELL AND METHOD OF MANUFACTURE FTO, DCX, TET1 CA1 22/4885CA2 166/4885CA9 550/4885
US-20260112694-A1 SYSTEM AND METHOD FOR IMPROVED BATTERY STRUCTURAL PROPERTIES PARG, PUF60, PHOSPHO1 CA1 85/4885CA2 741/4885CA9 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.